Shares of Smith & Nephew (FTSE:SN, NYSE:SNN) are up nearly 4% today after the British health products giant posted sales and earnings increases for the 1sst quarter.
Smith & Nephew
Studies suggest new breast screening standards | MassDevice.com On Call
MASSDEVICE ON CALL — Two studies published today in the Annals of Internal Medicine could influence the standard of care for breast screening, which was called into question by a U.S. Preventive Services Task Force report in 2009.
That report suggested that annual mammograms might cause more harm than good because of increased false positives leading to unnecessary biopsies and further testing – not to mention considerable anxiety for patients.
Diabetes: NeuroMetrix touts weight loss study at Joslin Diabetes Center | MassDevice.com On Call
MASSDEVICE ON CALL — Waltham, Mass.-based NeuroMetrix (NSDQ:NURO) announced its support of the Joslin Diabetes Center’s "Why Wait" program targeting obese patients with diabetes.
MassDevice.com +7 | The top 7 med-tech stories for the week of April 16, 2012.
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with MassDevice +7.
MassDevice.com +3 | The top 3 med-tech stories for April 17, 2012.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Smith & Nephew shareholder faction opposes CEO Bohuon’s $2.5M “golden hello” | Personnel Roundup
A significant chunk of Smith & Nephew‘s (FTSE:SN; NYSE:SNN) shareholders withheld their endorsement or voted outright against a $2.5 million "golden hello" for new CEO Olivier Bohuon after an advisory board recommended a veto.
Smith & Nephew adds Baroness Bottomley to board of directors | Personnel Moves
British orthopedic giant Smith & Nephew (NYSE:SNN) added former Parliament member and conservative politician Baroness Virginia Bottomley of Nettlestone to its board of directors.
Bottomley served in the U.K.’s House of Commons from 1984 to 2005, after which she was raised to "peerage," a term of ranking for British nobility.
J&J veteran Donald Casey takes helm of medical segment at Cardinal Health | Personnel Moves
Cardinal Health appointed Donald Casey Jr. to lead its $9 billion medical products and services division, effective next week.
HRS preview: St. Jude, Boston Scientific in the spotlight | Wall Street Beat
The foofaraw over St. Jude Medical‘s (NYSE:STJ) recalled Riata defibrillator leads is slated for top billing at the upcoming annual meeting of the Heart Rhythm Society in Boston, according to a pair of Leerink Swann analysts.
Device makers lack green initiative, report says | MassDevice.com On Call
MASSDEVICE ON CALL — A look at the top 10 medical device makers found that more than half had little to no environmental initiatives in place.
In a study conducted by Green Research, the companies with stainability initiatives were:
Boston Scientific launches Pluromed’s BackStop kidney stone treatment | Wall Street Beat
Boston Scientific (NYSE:BSX) launched its BackStop kidney stone treatment product in the U.S. and certain international markets this week.